Sign In
Buy FMS
$20.90
+0.350 (+1.70%)
At Close: Jun 03, 2026
Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis
08:00am, Wednesday, 03'rd Jun 2026
Global launch of a single, integrated digital platform connecting remote therapy monitoring and operational workflows for home dialysis programs Designed to simplify care processes for healthcare team
Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million
07:00am, Thursday, 28'th May 2026
BAD HOMBURG, Germany, May 28, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today announced the launch o
Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026
09:05am, Wednesday, 27'th May 2026
Hemodiafiltration (HDF) research reinforces Fresenius Medical Care's continued leadership in advancing evidence-based dialysis care and treatment personalization New research focuses on applying real-
Total volume of the share buyback is around EUR 1 billion over 12 months Share buyback expected to begin in the near future BAD HOMBURG, Germany, May 26, 2026 /PRNewswire/ -- Fresenius Medical Care (
Toronto Stock Exchange, Focus Graphite Inc., The View from the C-Suite
03:01pm, Thursday, 21'st May 2026
Toronto, Ontario--(Newsfile Corp. - May 21, 2026) - Dean Hanisch, Chief Executive Officer, Focus Graphite Inc. ("Focus Graphite Advanced Materials" or the "Company") (TSXV: FMS), shares the Company's
Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care
11:00am, Thursday, 21'st May 2026
Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care PR Newswire
Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care
10:13am, Thursday, 21'st May 2026
Shareholders approve proposed dividend of EUR 1.49 per share FME Reignite strategy launched in 2025 successfully drives the next phase of value creation 5008X CAREsystem introduced in U.S. clinics; fu
Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer
02:00pm, Wednesday, 20'th May 2026
Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer PR Newswire BAD HOMBURG, Germany, May 2
Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer
01:00pm, Wednesday, 20'th May 2026
BAD HOMBURG, Germany, May 20, 2026 /PRNewswire/ -- The Supervisory Board of Fresenius Medical Care AG, the world's leading provider of products and services for individuals with renal disease, today
FMS Stock Rises Despite Q1 Earnings & Sales Miss, Margins Expand
12:41pm, Wednesday, 06'th May 2026
Fresenius Medical's shares rise after Q1 earnings miss estimates as margin expansion and FME25+ savings support operating income growth.
Fresenius Medical Care AG (FMS) Q1 2026 Earnings Call Transcript
04:01pm, Tuesday, 05'th May 2026
Fresenius Medical Care AG (FMS) Q1 2026 Earnings Call Transcript
Fresenius Medical: The Undervaluation Is Getting Clearer
12:09pm, Tuesday, 05'th May 2026
Fresenius Medical Care is undervalued at a sub-10x P/E despite 7-9% AEPS growth and improved fundamentals. FMS has achieved 300-400 bps margin expansion, €800M+ in savings, and reduced leverage to 2
Organic revenue growth1 of 4% with growth in all operating segments Operating income2 grew 10%, resulting in further margin expansion to 10.1% FME25+ transformation program related one-time costs ma
Fresenius Medical Care Posts Lower Net Profit on One-Off Costs
03:22am, Tuesday, 05'th May 2026
The dialysis specialist started restructuring its U.S. network by exiting 64 of up to 100 clinics.
Fresenius Medical Care's revenue falls in Q1 as weak dollar takes toll
01:08am, Tuesday, 05'th May 2026
Fresenius Medical Care said on Tuesday its revenue fell 6% in the first quarter of 2026, weighed down by significant currency effects, mainly from the weak U.S. dollar, and recent
